{"schema_version":"1","generated_at":"2026-11-14T22:19:24.025Z","data_as_of":null,"url":"https://www.findmykol.com/kol/filip-ionescu","json_url":"https://www.findmykol.com/kol/filip-ionescu/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"filip-ionescu","name":"Filip Ionescu","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Morgantown","state":"WV","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1003302001","orcid":"0000-0003-3097-8985","openalex":"A5005275342"},"summary":"Filip Ionescu is an Oncology physician. OpenAlex indexes 90 publications with 656 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":90,"cited_by_count":656,"h_index":14,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Caris MPI, Inc.","program_year":2025,"amount_usd":24.45,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003302001"},{"payer":"PFIZER INC.","program_year":2024,"amount_usd":20.33,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003302001"},{"payer":"Astellas Pharma US Inc","program_year":2023,"amount_usd":99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003302001"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1003302001","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Nervous system","share_pct":62.5,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":62.5,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":14}]},{"area":"Cancer & immunology","share_pct":37.5,"classes_total":1,"classes":[{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":37.5,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":82,"facility_pct":18},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Cytopenias and Infectious Complications Following CD19-Directed CAR-T cell Therapy in Patients with B-ALL","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.169","status":"verified"},{"title":"Baseline and Peri-Infusion Cytokine Patterns Correlate with Immune-Mediated Toxicities Following CD19 CAR T-cell (CAR T) Therapy in relapsed/refractory (r/r) Adult B-cell Acute Lymphoblastic Leukemia (B ALL)","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.166","status":"verified"},{"title":"The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2024.7078","status":"verified"},{"title":"Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-Preserving Trimodality Therapy","year":2025,"journal":"The Journal of Urology","source_url":"https://doi.org/10.1097/ju.0000000000004849","status":"verified"},{"title":"Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium","year":2025,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.08.015","status":"verified"}],"source":"works"},"contact":{"address_1":"1200 J D ANDERSON DR","city":"Morgantown","state":"WV","zip":"265053494","phone":"304-598-6560","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1003302001","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-08-04","provider_certified":"2025-08-04","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}